Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha(1)-antitrypsin deficiency

被引:16
|
作者
Mahadeva, R
Zhao, MH
Stewart, S
Cary, N
Flower, C
Lockwood, M
Shneerson, J
机构
[1] ADDENBROOKES HOSP,DEPT RESP MED,CAMBRIDGE,ENGLAND
[2] ADDENBROOKES HOSP,DEPT MED,CAMBRIDGE,ENGLAND
[3] ADDENBROOKES HOSP,DEPT RADIOL,CAMBRIDGE,ENGLAND
[4] PAPWORTH HOSP,DEPT PATHOL,CAMBRIDGE CB3 8RE,ENGLAND
关键词
alpha(1)-antitrypsin deficiency; antineutrophil cytoplasmic antibody; bactericidal/permeability-increasing protein; bronchiectasis;
D O I
10.1378/chest.112.6.1699
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A patient with alpha(1)-antitrypsin deficiency is reported herein; this subject developed aggressive bronchial disease and recurrent cutaneous vasculitis after pulmonary infection with Pseudomonas aeruginosa. Autoantibodies to neutrophil cytoplasmic antigens were detected, which produced granular cytoplasmic staining by indirect immunofluorescence with specificity for a newly characterized antigen: bactericidal/permeability-increasing protein (BPI). The bronchial disease and vasculitis improved, and the IgA anti-BPI titer fell after antipseudomonal treatment. This raises the possibility that anti-BPI antibodies contributed to both the bronchial disease and vasculitis.
引用
收藏
页码:1699 / 1701
页数:3
相关论文
共 50 条
  • [1] The antiangiogenic properties of bactericidal/permeability-increasing protein (BPI)
    van der Schaft, DWJ
    Wagstaff, J
    Mayo, KH
    Griffioen, AW
    ANNALS OF MEDICINE, 2002, 34 (01) : 19 - 27
  • [2] BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (BPI) IS AN IMPORTANT ANTIGEN FOR ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES (ANCA) IN VASCULITIS
    ZHAO, MH
    JONES, SJ
    LOCKWOOD, CM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 99 (01) : 49 - 56
  • [3] Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein
    Schinke, S
    Fellermann, K
    Herlyn, K
    Reichel, PH
    Fundke, R
    Stange, EF
    Gross, WFL
    Schultz, H
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) : 763 - 770
  • [4] Time-resolved fluoroimmunoassay for bactericidal permeability-increasing protein
    Haggblom, JO
    JokilammiSiltanen, AB
    Peuravuori, H
    Nevalainen, TJ
    MEDIATORS OF INFLAMMATION, 1996, 5 (01) : 47 - 50
  • [5] Presence of bactericidal/permeability-increasing protein in human and rat skin
    Takahashi, M
    Horiuchi, Y
    Tezuka, T
    EXPERIMENTAL DERMATOLOGY, 2004, 13 (01) : 55 - 60
  • [6] The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease
    Schultz, Hendrik
    Weiss, Jerrold P.
    CLINICA CHIMICA ACTA, 2007, 384 (1-2) : 12 - 23
  • [7] Bactericidal/Permeability-Increasing Protein Is an Enhancer of Bacterial Lipoprotein Recognition
    Buelow, Sigrid
    Zeller, Lisa
    Werner, Maren
    Toelge, Martina
    Holzinger, Jonas
    Entzian, Clemens
    Schubert, Thomas
    Waldow, Franziska
    Gisch, Nicolas
    Hammerschmidt, Sven
    Gessner, Andre
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [8] Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis
    Haapamäki, MM
    Häggblom, JO
    Grönroos, JM
    Pekkala, E
    Alanen, K
    Nevalainen, TJ
    HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2273 - 2277
  • [9] Bactericidal Permeability-Increasing Protein (BPI) Inhibits Mycobacterium tuberculosis Growth
    Guzman-Beltran, Silvia
    Juarez, Esmeralda
    Cruz-Munoz, Brenda L.
    Paez-Cisneros, Cesar A.
    Sarabia, Carmen
    Gonzalez, Yolanda
    BIOMOLECULES, 2024, 14 (04)
  • [10] alpha(1)-Antitrypsin deficiency: Evaluation of bronchiectasis with CT
    King, MA
    Stone, JA
    Diaz, PT
    Mueller, CF
    Becker, WJ
    Gadek, JE
    RADIOLOGY, 1996, 199 (01) : 137 - 141